Hello Anyone having really low blood sugar episodes on Retatrutide?

Disclaimer: Research peptides only. Educational purposes. Not medical advice. Talk to your doctor. I've always said: research with whatever allows you to stay on plan and keeps you in a deficit. But after experimenting with both extensively, I need to rethink this. My Experience: Tirzepatide → food noise basically gone while still being able to eat Retatrutide + cagri → still thinking about food way too much Even adding cagrilintide to reta hasn't given me the same mental freedom as tirz. And that's making me question whether reta's theoretical advantages are actually worth it for most people. What the Clinical Data Shows: Tirzepatide (SURMOUNT trials): Participants consistently reported serious appetite suppression. Many said they basically stopped thinking about food between meals. Retatrutide (Phase 2 trials): Weight loss was impressive (24% at 48 weeks), but appetite control was hit-or-miss. Some people experienced it, others didn't. The pattern is clear: tirz delivers consistent appetite suppression for almost everyone. Reta is more variable. The Part Everyone Overlooks: Yeah, reta might burn slightly more fat because of glucagon receptor activation. But here's the reality— Most researchers don't have their diet and training dialed in yet. And getting THOSE fundamentals right will do way more for fat loss than reta's glucagon effect ever will. You can replicate reta's fat-burning advantages through: - Increased cardio - Lipo-C injections - L-carnitine supplementation - Fasted training sessions - Consistent resistance training Here's my honest take: If you dial in nutrition, training, and sleep, you'll get comparable results with tirz—without fighting hunger all day. Reta's edge only matters if everything else is already optimized. For most people, it's not. What I'm Seeing: This pattern keeps repeating: researchers switch from tirz to reta, then come back—not because tirz made everything effortless, but because it made staying on plan manageable.

Everyone's focused on the incredible fat loss results with retatrutide, but there's a critical side effect that's flying under the radar: significantly elevated resting heart rate. This isn't your typical GLP-1 nausea that goes away in a few days. This is a cardiovascular effect that demands respect and careful attention. What's Actually Happening in Your Research Models? Retatrutide is a triple agonist - GIP/GLP-1/glucagon. That third component, glucagon, is what sets it apart from tirzepatide and semaglutide, and it's also what's driving this side effect. Here's the mechanism: Glucagon receptor activation: - Dramatically increases metabolic rate and energy expenditure (great for fat loss) - Activates the sympathetic nervous system (your "fight or flight" response) - Stimulates thermogenesis (heat production) - Increases cardiac output to support elevated metabolism The result? Your heart starts beating faster to keep up with the increased metabolic demand. This isn't a bug - it's a feature of how the compound works. But it comes with real implications. The Clinical Trial Data In Eli Lilly's Phase 2 trials: - Average RHR increases of 5-10 bpm were common - Some subjects saw increases of 15+ bpm - The effect was dose-dependent (higher doses = higher RHR) - The elevation persisted throughout treatment duration - It didn't just "go away" after a few weeks like GI side effects To put this in perspective: if your baseline RHR is 65 bpm and you jump to 80 bpm, that's your heart beating an extra 21,600 times per day. Over a year? That's nearly 8 million extra heartbeats. Why This Matters More Than You Think An elevated RHR isn't just uncomfortable - it has real physiological implications: Cardiovascular strain: - Increased workload on the heart muscle - Higher oxygen demand - Potential for increased blood pressure - Greater stress on the cardiovascular system long-term Quality of life impacts: - Feeling "wired" or anxious - Poor sleep quality - Reduced exercise capacity - Palpitations or awareness of heartbeat

Hey everyone, Just pushed fresh stock updates across peptideprice.store. With everything happening in the space right now, staying on top of price changes and inventory is more important than ever. Quick updates: - Valor may have additional Reta testing results coming back today (I'll update as soon as Kyle sends the new inventory) - Currently only Reta 36mg is in stock there - Multiple vendors have adjusted pricing - worth checking the comparison tool before you order I know it's been a weird time in the peptide world lately. Uncertainty, vendor changes, platform bans - the whole nine yards. But here's the thing: as long as you guys keep supporting the site, it's never going anywhere. This platform was built for you, by someone who was just as frustrated with the vendor landscape as you probably are. Drop a comment👇 below if you'd still use PeptidePrice for all your research needs, regardless of what happens in the industry. Your support means everything - let's weather this storm together. - Derek

We did it! We've had an amazing launch of our site! 🚀 From the bottom of our hearts, thank you. Launching His & Hers was difficult and riddled with roadblocks. We created His & Hers to supply a quality product line curated by a trustworthy team to people that deserve honesty and transparency. Thanks to your orders, messages, and support it finally happened. Because of you, we’re already restocking your favorites and adding new products very soon. Here's a sneak peak as to what's coming: GLOW KLOW Tesamorelin BPC-157 TB-500 BPC-157 + TB-500 Retatrutide + Cagrilintide ..and MANY more!! As a sign of true gratitude, we'd like to give back to this community by performing a giveaway in September! We will announce more details in the coming weeks. As a reminder, our Labor Day sale ends on Sept 2nd at 12p Eastern! Be sure to take advantage of some amazing deals with Derek's discount before the sale ends! Visit our store: https://his-and-hers.com/?ref=derek Thanks again everyone, we really appreciate you all so very much! Sincerely, Brett & Oliver from His & Hers